文献速递内脏/肾动脉与血管畸形

症状性孤立性自发性肾动脉夹层保守治疗的临床结局及与肠系膜上动脉夹层的比较

Clinical Outcomes of Conservative Treatment in Patients with Symptomatic Isolated Spontaneous Renal Artery Dissection and Comparison with Superior Mesenteric Artery Dissection.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2018-05-30

单中心观察性比较研究分析前瞻性内脏动脉夹层登记数据,纳入2010年6月至2016年12月23例症状性孤立性自发性肾动脉夹层(SRAD)初始保守治疗患者,并与同期40例症状性孤立性自发性肠系膜上动脉夹层(SSMAD)比较。中位随访20个月,SRAD主要结局发生率为39%(9/23),夹层相关死亡率为17%(4/23),均显著高于SSMAD的10%和0%。作者认为伴夹层相关动脉瘤及真腔狭窄的症状性孤立性SRAD可能危及生命,对保守治疗无效者应考虑积极外科或腔内干预。

要点

  • 症状性孤立性SRAD保守治疗主要结局发生率为39%(9/23),夹层相关死亡率为17%(4/23)。
  • SRAD主要结局发生率39% vs SSMAD 10%(p=.009),夹层相关死亡率17% vs 0%(p=.016)。
  • 无动脉瘤或真腔闭塞的患者未发生夹层相关死亡。

核心结论

  • 尽管分析仅涉及少量患者,症状性孤立性SRAD伴夹层相关动脉瘤和真腔狭窄是可能危及生命的状况,对保守治疗无效者应考虑积极外科或腔内干预。

研究设计与样本

  • 单中心观察性比较研究,回顾性分析前瞻性内脏动脉夹层登记数据。
  • 纳入2010年6月至2016年12月23例症状性孤立性SRAD初始接受保守治疗的患者,并与同期40例症状性孤立性SSMAD患者比较。
  • 主要结局为夹层加重需干预和夹层相关死亡。

主要发现

  • 中位随访20个月(范围0-63个月),症状性孤立性SRAD主要结局发生率为39%(9/23),夹层相关死亡率为17%(4/23)。
  • 全部死亡原因均为夹层动脉瘤突然破裂伴显著真腔狭窄。
  • 无动脉瘤或真腔闭塞的患者均无夹层相关死亡。
  • 与症状性孤立性SSMAD初始保守治疗患者相比,SRAD主要结局发生率39% vs 10%(p=.009),夹层相关死亡率17% vs 0%(p=.016),差异有统计学意义。

临床怎么用

  • 作者认为,伴夹层相关动脉瘤和真腔狭窄的症状性孤立性SRAD可能危及生命,对保守治疗无效者应考虑积极外科或腔内干预。

局限性

  • 作者指出本分析仅涉及少量患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The aims of this study were to report the clinical outcomes of conservative medical treatment in patients with symptomatic isolated spontaneous renal artery dissection (SRAD) and compare them with those of spontaneous superior mesenteric artery dissection (SSMAD). METHODS: This was a single centre, observational comparative study between SRAD and SSMAD. Data from a prospective visceral artery dissection registry were analysed retrospectively. Between June 2010 and December 2016, 23 consecutive patients with symptomatic isolated SRAD who initially received conservative medical treatment were included. The primary outcomes were the aggravation of dissection requiring intervention and dissection related mortality. To evaluate the prognosis of symptomatic isolated SRAD, the clinical outcomes of isolated SRAD were compared with those of symptomatic isolated SSMAD (n = 40) during the same study period. RESULTS: The primary outcome incidence was 39% (9/23) in patients with symptomatic isolated SRAD during the median follow up period of 20 months (range 0-63 months). The dissection related mortality rate was 17% (4/23), and the cause of death in all cases was an abrupt rupture of the dissecting aneurysm with significant true lumen stenosis. None of the patients without aneurysm or with true lumen occlusion had dissection related mortality. During the same study period, compared with the patients with symptomatic isolated SSMAD who initially received conservative medical treatment, the primary outcome incidence (39% vs. 10%, p = .009) and dissection related mortality rate (17% vs. 0%, p = .016) were statistically significantly higher in patients with symptomatic isolated SRAD. CONCLUSIONS: Although the present analysis involved only a small number of patients, it revealed that symptomatic isolated SRAD with dissection related aneurysm and true lumen stenosis is a potentially life threatening condition and that aggressive surgical or endovascular interventions should be considered in these patients, who are refractory to conservative medical treatment.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Jeong MJ, Kwon H, Kim A, et al. Clinical Outcomes of Conservative Treatment in Patients with Symptomatic Isolated Spontaneous Renal Artery Dissection and Comparison with Superior Mesenteric Artery Dissection. Eur J Vasc Endovasc Surg. 2018. PMID: 29859822. doi:10.1016/j.ejvs.2018.05.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。